BioSpace News Archive

Drug Development

Ampio Suspends Patient Enrollment in its Phase 3 Study of Ampion for Severe Osteoarthritis of the Knee and Explores Other Options to Complete Trial

Ampio Pharmaceuticals, Inc., a pre-revenue development stage biopharmaceutical company announced that it has suspended patient enrollment in its Phase 3 clinical trial of Ampion for the treatment of severe osteoarthritis of the knee.

March 24, 2020
·
4 min read
Biotech Beach

Oncolytics Biotech® Announces Favourable AWARE-1 Safety Update

Oncolytics Biotech® Inc. announced a favourable assessment from the Safety Committee following review of data from the window of opportunity study in early-stage breast cancer, known as AWARE-1.

March 24, 2020
·
7 min read
Business

Triumvira Immunologics and Lonza Announce Collaboration to Develop Innovative Point-of-Care Manufacturing for TAC T-Cell Therapeutic Targeting Solid Tumors

Collaboration between Triumvira Immunologics and Lonza will leverage the innovative Cocoon® Platform for novel TAC01-HER2 program

March 24, 2020
·
5 min read
Business

scPharmaceuticals Inc. Reports Fourth Quarter and Year Ended 2019 Financial Results and Provides Business Update

scPharmaceuticals Inc. announced financial results for the fourth quarter and year ended December 31, 2019 and provided a business update.

March 24, 2020
·
9 min read
BioMidwest

Alliance Rubber Co. Announces Availability of Antimicrobial Tourniquets

Non-Latex® Tourniquets with Antimicrobial Product Protection include an antimicrobial agent to make them resistant to microbes such as bacteria, mold, and fungi.*

March 24, 2020
·
1 min read
Drug Development

Data from Phase 3 TRuE-AD Trials of Ruxolitinib Cream in Atopic Dermatitis to be Presented at the 2020 Revolutionizing Atopic Dermatitis Virtual Conference

Incyte (Nasdaq:INCY) today announced that data from the Phase 3 TRuE-AD program evaluating ruxolitinib cream for the treatment of patients with mild-to-moderate atopic dermatitis have been accepted for presentation during the Late Breaking Abstracts session at the 2020 Revolutionizing Atopic Dermatitis (RAD) Virtual Conference to be held on Sunday, April 5, 2020.

March 24, 2020
·
1 min read
BioMidwest

GE Healthcare Takes Additional Actions to Help Clinicians Combat Coronavirus

GE Healthcare and Ford collaborate to accelerate and scale ventilator production, supporting clinicians in the treatment of COVID-19 patients

March 24, 2020
·
2 min read
Biotech Bay

DiaCarta Inc. has filed for EUA with the FDA and has received CE mark for its highly sensitive QuantiVirus™ SARS-CoV-2 Test

DiaCarta Inc., a precision molecular diagnostic company, announced today that it has filed for Emergency Use Authorization (EUA) with the US FDA for its QuantiVirus™ SARS-CoV-2 test and has validated the COVID-19 diagnostic test in its own CLIA certified lab in Richmond, CA to provide testing services for healthcare providers an

March 24, 2020
·
2 min read
Biotech Beach

Emmaus Life Sciences Provides Update in Response to the Coronavirus (COVID-19) Pandemic

Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease (SCD) treatment, announced today several steps it has taken in response to the Coronavirus (COVID-19) pandemic.

March 24, 2020
·
4 min read
InSphero offers free safety testing in 3D InSight™ Human Liver Models for exploratory COVID-19 treatments

Organizations working on new medications and vaccine formulations may request free safety testing using preclinical liver models that identify potential for toxic effects in humans.

March 24, 2020
·
3 min read